Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Wronski

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|July 9, 2022
Efficient Adsorption of Chromium Ions from Aqueous Solutions by Plant-Derived SilicaIbeth Guevara-Lora, Norbert Wronski, Anna Bialas, et al.
Cellular Signalling|October 23, 2023
RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt/β-catenin signaling in melanoma cells and tumor growth in vivoNorbert Wronski, Ewelina Madej, Maja Grabacka, et al.
Photochemistry and Photobiology|April 8, 2023
Tetraacetyl riboflavin derivative mediates caspase 3/7 activation via MAPK in A431 cells upon blue light influenceIzabela Buniowska, Norbert Wronski, Małgorzata Insinska-Rak, et al.
Biomolecules|January 8, 2025
RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced ApoptosisBartlomiej Olajossy, Norbert Wronski, Ewelina Madej, et al.
Journal of Cancer Research and Clinical Oncology|April 24, 2024
The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cellsEwelina Madej, Anna Lisek, Anna A Brożyna, et al.
Scientific Reports|June 23, 2026
RIPK4 is associated with altered bioenergetics and invasive in melanoma three-dimensional modelsNorbert Wronski, Jan Wolnik, Wacław Tworzydło, et al.
Cancers|February 11, 2023
Vemurafenib and Dabrafenib Downregulates RIPK4 LevelEwelina Madej, Anna A Brożyna, Agnieszka Adamczyk, et al.
Molecular Oncology|February 9, 2026
RIPK4 function interferes with melanoma cell adhesion and metastasisNorbert Wronski, Sławomir Lasota, Ewelina Madej, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|July 9, 2022
Efficient Adsorption of Chromium Ions from Aqueous Solutions by Plant-Derived SilicaIbeth Guevara-Lora, Norbert Wronski, Anna Bialas, et al.
Cellular Signalling|October 23, 2023
RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt/β-catenin signaling in melanoma cells and tumor growth in vivoNorbert Wronski, Ewelina Madej, Maja Grabacka, et al.
Photochemistry and Photobiology|April 8, 2023
Tetraacetyl riboflavin derivative mediates caspase 3/7 activation via MAPK in A431 cells upon blue light influenceIzabela Buniowska, Norbert Wronski, Małgorzata Insinska-Rak, et al.
Biomolecules|January 8, 2025
RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced ApoptosisBartlomiej Olajossy, Norbert Wronski, Ewelina Madej, et al.
Journal of Cancer Research and Clinical Oncology|April 24, 2024
The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cellsEwelina Madej, Anna Lisek, Anna A Brożyna, et al.
Scientific Reports|June 23, 2026
RIPK4 is associated with altered bioenergetics and invasive in melanoma three-dimensional modelsNorbert Wronski, Jan Wolnik, Wacław Tworzydło, et al.
Cancers|February 11, 2023
Vemurafenib and Dabrafenib Downregulates RIPK4 LevelEwelina Madej, Anna A Brożyna, Agnieszka Adamczyk, et al.
Molecular Oncology|February 9, 2026
RIPK4 function interferes with melanoma cell adhesion and metastasisNorbert Wronski, Sławomir Lasota, Ewelina Madej, et al.
Pageof 1